Progyny Inc (NASDAQ: PGNY) has a higher price-to-earnings ratio of 26.36x compared to its average ratio, The 36-month beta value for PGNY is at 1.37. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for PGNY is 76.48M, and currently, shorts hold a 13.03% of that float. The average trading volume for PGNY on November 08, 2024 was 2.29M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
PGNY) stock’s latest price update
The stock of Progyny Inc (NASDAQ: PGNY) has increased by 0.92 when compared to last closing price of 16.38. Despite this, the company has experienced a 9.83% gain in its stock price over the last five trading sessions. accesswire.com reported 2024-11-04 that NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
PGNY’s Market Performance
PGNY’s stock has risen by 9.83% in the past week, with a monthly rise of 0.55% and a quarterly drop of -23.51%. The volatility ratio for the week is 3.87% while the volatility levels for the last 30 days are 3.62% for Progyny Inc The simple moving average for the last 20 days is 4.03% for PGNY stock, with a simple moving average of -40.80% for the last 200 days.
Analysts’ Opinion of PGNY
Leerink Partners, on the other hand, stated in their research note that they expect to see PGNY reach a price target of $25, previously predicting the price at $31. The rating they have provided for PGNY stocks is “Market Perform” according to the report published on August 07th, 2024.
Canaccord Genuity gave a rating of “Hold” to PGNY, setting the target price at $24 in the report published on August 07th of the current year.
PGNY Trading at -9.43% from the 50-Day Moving Average
After a stumble in the market that brought PGNY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.72% of loss for the given period.
Volatility was left at 3.62%, however, over the last 30 days, the volatility rate increased by 3.87%, as shares surge +0.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.10% lower at present.
During the last 5 trading sessions, PGNY rose by +9.83%, which changed the moving average for the period of 200-days by -56.78% in comparison to the 20-day moving average, which settled at $15.89. In addition, Progyny Inc saw -55.54% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PGNY starting from Sturmer Michael E, who sale 9,030 shares at the price of $30.00 back on Jul 16 ’24. After this action, Sturmer Michael E now owns 362,583 shares of Progyny Inc, valued at $270,900 using the latest closing price.
Scott Cheryl, the Director of Progyny Inc, sale 1,462 shares at $28.39 during a trade that took place back on Jun 28 ’24, which means that Scott Cheryl is holding 10,098 shares at $41,506 based on the most recent closing price.
Stock Fundamentals for PGNY
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.22 for the gross margin
The net margin for Progyny Inc stands at 0.06. The total capital return value is set at 0.15. Equity return is now at value 13.56, with 9.09 for asset returns.
Based on Progyny Inc (PGNY), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 8.77.
Currently, EBITDA for the company is 64.47 million with net debt to EBITDA at -1.03. When we switch over and look at the enterprise to sales, we see a ratio of 1.25. The receivables turnover for the company is 3.86for trailing twelve months and the total asset turnover is 1.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.58.
Conclusion
In conclusion, Progyny Inc (PGNY) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
